{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:14:54Z","timestamp":1789146894129,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chunguang Yang","award":["Hubei key R&D project (2023DJC160)"],"award-info":[{"award-number":["Hubei key R&D project (2023DJC160)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-17990-7","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:29:34Z","timestamp":1755109774000},"page":"730-739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing Clinically Significant Prostate Cancer Diagnosis Models Based on Serum Methylation Levels of Four Genes"],"prefix":"10.1245","volume":"33","author":[{"given":"Jinyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaogang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"3","key":"17990_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10437","key":"17990_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722.","journal-title":"Lancet"},{"issue":"8","key":"17990_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472\u201384.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"17990_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.ccell.2024.06.003","volume":"42","author":"I Casanova-Salas","year":"2024","unstructured":"Casanova-Salas I, Aguilar D, Cordoba-Terreros S, et al. Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution. Cancer Cell. 2024;42(7):1301\u201312.","journal-title":"Cancer Cell"},{"issue":"8","key":"17990_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12491","volume":"13","author":"S Jiang","year":"2024","unstructured":"Jiang S, Lu F, Chen J, et al. UPCARE: urinary extracellular vesicles-derived prostate cancer assessment for risk evaluation. J Extracell Vesicles. 2024;13(8):e12491.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"17990_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415\u201328.","journal-title":"Nat Rev Genet"},{"issue":"16","key":"17990_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/pros.23093","volume":"75","author":"MS Geybels","year":"2015","unstructured":"Geybels MS, Zhao S, Wong CJ, et al. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. Prostate. 2015;75(16):1941\u201350.","journal-title":"Prostate"},{"issue":"2","key":"17990_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","volume":"6","author":"SB Baylin","year":"2006","unstructured":"Baylin SB, Ohm JE. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction. Nat Rev Cancer. 2006;6(2):107\u201316.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"17990_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/pros.23289","volume":"77","author":"LM FitzGerald","year":"2017","unstructured":"FitzGerald LM, Naeem H, Makalic E, et al. Genome-wide measures of peripheral blood DNA methylation and prostate cancer risk in a prospective nested case-control study. Prostate. 2017;77(5):471\u20138.","journal-title":"Prostate"},{"issue":"11","key":"17990_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nmat4997","volume":"16","author":"RH Xu","year":"2017","unstructured":"Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16(11):1155\u201361.","journal-title":"Nat Mater"},{"issue":"12","key":"17990_CR11","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang J, Ruan W, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Investig. 2020;130(12):6278\u201389.","journal-title":"J Clin Investig"},{"issue":"24","key":"17990_CR12","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.3390\/cancers13246234","volume":"13","author":"O Bryzgunova","year":"2021","unstructured":"Bryzgunova O, Bondar A, Ruzankin P, et al. Locus-specific methylation of GSTP1, RNF219, and KIAA1539 Genes with single molecule resolution in cell-free DNA from healthy donors and prostate tumor patients: application in diagnostics. Cancers (Basel). 2021;13(24):6234.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"17990_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1158\/1940-6207.CAPR-22-0485","volume":"16","author":"H Gupta","year":"2023","unstructured":"Gupta H, Inoue H, Nakai Y, et al. Progressive spreading of DNA methylation in the GSTP1 promoter CpG island across transitions from precursors to invasive prostate cancer. Cancer Prev Res (Phila). 2023;16(8):449\u201360.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"17990_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/bjc.2011.143","volume":"105","author":"T Wu","year":"2011","unstructured":"Wu T, Giovannucci E, Welge J, et al. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer. 2011;105(1):65\u201373.","journal-title":"Br J Cancer"},{"issue":"3","key":"17990_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.eururo.2018.11.001","volume":"76","author":"KL Mahon","year":"2019","unstructured":"Mahon KL, Qu W, Lin HM, et al. Serum-free methylated glutathione S-transferase 1 DNA levels, survival, and response to docetaxel in metastatic, castration-resistant prostate cancer: post hoc analyses of data from a phase 3 trial. Eur Urol. 2019;76(3):306\u201312.","journal-title":"Eur Urol"},{"issue":"44","key":"17990_CR16","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1038\/sj.onc.1205814","volume":"21","author":"L Liu","year":"2002","unstructured":"Liu L, Yoon JH, Dammann R, et al. Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene. 2002;21(44):6835\u201340.","journal-title":"Oncogene"},{"issue":"2","key":"17990_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2003.11.027","volume":"205","author":"K Woodson","year":"2004","unstructured":"Woodson K, Hanson J, Tangrea J. A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett. 2004;205(2):181\u20138.","journal-title":"Cancer Lett"},{"issue":"10","key":"17990_CR18","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1002\/ijc.25908","volume":"129","author":"L Liu","year":"2011","unstructured":"Liu L, Kron KJ, Pethe VV, et al. Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer. 2011;129(10):2454\u201362.","journal-title":"Int J Cancer"},{"issue":"1","key":"17990_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1476-4598-12-99","volume":"12","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Amin KS, Jagadeesh S, et al. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer. 2013;12(1):99.","journal-title":"Mol Cancer"},{"issue":"17","key":"17990_CR20","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.3390\/cancers13174459","volume":"13","author":"M Friedemann","year":"2021","unstructured":"Friedemann M, Horn F, Gutewort K, et al. Increased sensitivity of detection of RASSF1A and GSTP1 DNA fragments in serum of prostate cancer patients: optimisation of diagnostics using OBBPA-ddPCR. Cancers (Basel). 2021;13(17):4459.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"17990_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728222.10.1.15","volume":"10","author":"VS Budhram-Mahadeo","year":"2006","unstructured":"Budhram-Mahadeo VS, Latchman DS. Targeting Brn-3b in breast cancer therapy. Expert Opin Ther Targets. 2006;10(1):15\u201325.","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"17990_CR22","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1111\/cas.15089","volume":"112","author":"K Guo","year":"2021","unstructured":"Guo K, Wang P, Zhang L, et al. Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog-mediated epithelial-mesenchymal transition. Cancer Sci. 2021;112(10):4176\u201386.","journal-title":"Cancer Sci"},{"issue":"95","key":"17990_CR23","doi-asserted-by":"publisher","first-page":"36770","DOI":"10.18632\/oncotarget.26371","volume":"9","author":"LJ Maskell","year":"2018","unstructured":"Maskell LJ, Mahadeo AV, Budhram-Mahadeo VS. POU4F2\/Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells. Oncotarget. 2018;9(95):36770\u20139.","journal-title":"Oncotarget"},{"issue":"10","key":"17990_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1357-2725(01)00069-3","volume":"33","author":"V Budhram-Mahadeo","year":"2001","unstructured":"Budhram-Mahadeo V, Moore A, Morris PJ, et al. The closely related POU family transcription factors Brn-3a and Brn-3b are expressed in distinct cell types in the testis. Int J Biochem Cell Biol. 2001;33(10):1027\u201339.","journal-title":"Int J Biochem Cell Biol"},{"key":"17990_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canlet.2017.03.029","volume":"396","author":"A Van Tongelen","year":"2017","unstructured":"Van Tongelen A, Loriot A, De Smet C. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Lett. 2017;396:130\u20137.","journal-title":"Cancer Lett"},{"issue":"8","key":"17990_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","volume":"52","author":"SG Zhao","year":"2020","unstructured":"Zhao SG, Chen WS, Li H, et al. The DNA methylation landscape of advanced prostate cancer. Nat Genet. 2020;52(8):778\u201389.","journal-title":"Nat Genet"},{"key":"17990_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.04.009","volume":"166","author":"CE Massie","year":"2017","unstructured":"Massie CE, Mills IG, Lynch AG. The importance of DNA methylation in prostate cancer development. J Steroid Biochem Mol Biol. 2017;166:1\u201315.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"17990_CR28","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011\u201325.","journal-title":"Cell"},{"issue":"7801","key":"17990_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li J, Xu C, Lee HJ, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580(7801):93\u20139.","journal-title":"Nature"},{"issue":"2","key":"17990_CR30","first-page":"99","volume":"35","author":"TB Demircan","year":"2020","unstructured":"Demircan TB, Turan T, Yucel B, et al. Aberrant SOCS3 promoter methylation as a noninvasive diagnostic biomarker for locally advanced prostate cancer. Medeni Med J. 2020;35(2):99\u2013105.","journal-title":"Medeni Med J"},{"issue":"12","key":"17990_CR31","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/pros.23385","volume":"77","author":"L Van Neste","year":"2017","unstructured":"Van Neste L, Groskopf J, Grizzle WE, et al. Epigenetic risk score improves prostate cancer risk assessment. Prostate. 2017;77(12):1259\u201364.","journal-title":"Prostate"},{"issue":"9","key":"17990_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203322","volume":"13","author":"E Moses-Fynn","year":"2018","unstructured":"Moses-Fynn E, Tang W, Beyene D, et al. Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men. PLoS ONE. 2018;13(9):e203322.","journal-title":"PLoS ONE"},{"issue":"4","key":"17990_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","volume":"73","author":"V Cucchiara","year":"2018","unstructured":"Cucchiara V, Cooperberg MR, Dall\u2019Era M, et al. Genomic markers in prostate cancer decision making. Eur Urol. 2018;73(4):572\u201382.","journal-title":"Eur Urol"},{"issue":"1","key":"17990_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","volume":"70","author":"SA Tomlins","year":"2016","unstructured":"Tomlins SA, Day JR, Lonigro RJ, et al. Urine TMPRSS2:ERG Plus PCA3 for individualized prostate cancer risk assessment. Eur Urol. 2016;70(1):45\u201353.","journal-title":"Eur Urol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17990-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:08:55Z","timestamp":1765289335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17990-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["17990"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17990-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This study was approved by the ethics committee of the Medical Ethical Committee of Tongji Hospital of Huazhong University of Science and Technology (IRB ID: TJ-IRB20231129).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Lifespan institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}